1315 Capital Acquires SciSafe from BioLife Solutions

Sciens Building Solutions Acquires Fire Safe Protection Services

August 19, 2026

Industrial Services

Sciens Building Solutions welcomed Houston, Texas-based Fire Safe Protection Services into its U.S. portfolio. Fire Safe Protection Services provides integrated fire, security, sprinkler, monitoring, and communication systems across healthcare, education, commercial, and mixed-use facilities in the Houston market.

Repligen Completes Acquisition of BioLife Solutions

July 23, 2026

Medical Devices

Repligen agreed to acquire BioLife Solutions in a cash-and-stock transaction valued at approximately $1.5 billion, and later announced that the acquisition was completed. The deal expands Repligen’s cell and gene therapy offering with BioLife’s biopreservation media and cell-processing products, while broadening BioLife’s access to Repligen’s global commercial reach.

Carlyle Acquires Majority Stake in Sciens Building Solutions

November 9, 2021

Industrial Services

Funds managed by global investment firm Carlyle acquired a majority stake in Sciens Building Solutions from Huron Capital, with Sciens' senior management and Huron retaining minority equity and a board seat. The investment will support Sciens' growth strategy — accelerating organic investment and M&A to expand its fire and life safety platform across commercial, institutional and government end markets. Terms were not disclosed.

BioLife Solutions Acquires SciSafe

September 21, 2020

Healthcare Services

BioLife Solutions, Inc. (NASDAQ: BLFS) has entered into a definitive agreement to acquire SciSafe, a privately held multi-facility biostorage provider serving the cell and gene therapy and pharmaceutical industries. BioLife will pay $15 million cash and $15 million in newly issued BioLife common shares for 100% of SciSafe, with up to 626,000 additional shares earnable based on revenue milestones; the deal is expected to close on September 30.

1315 Capital Acquires Biocoat, Inc.

January 16, 2019

Medical Devices

Philadelphia-based healthcare investment firm 1315 Capital has acquired Biocoat, Inc., a Horsham, Pennsylvania specialty manufacturer of hydrophilic biomaterial coatings for medical devices; the transaction closed on December 20, 2018. 1315 Capital's investment will provide expansion and growth capital to accelerate R&D, expand Biocoat's operating model, and support broader commercial efforts across neurovascular, cardiovascular, peripheral, and ophthalmic end markets.

Altaris and Investor Group Recapitalize CSafe Global; Frazier Healthcare Partners Among New Investors

October 6, 2016

Manufacturing

Altaris Capital Partners announced a recapitalization of CSafe Global with an investor group that includes funds managed by Frazier Healthcare Partners; Altaris will retain a minority stake. CSafe Global, headquartered in Monroe, Ohio, is a provider of active and passive cold-chain packaging solutions serving the biopharmaceutical industry and will use the transaction to support continued growth and capability expansion.